CA2086484A1 - Implantable infusion device - Google Patents
Implantable infusion deviceInfo
- Publication number
- CA2086484A1 CA2086484A1 CA002086484A CA2086484A CA2086484A1 CA 2086484 A1 CA2086484 A1 CA 2086484A1 CA 002086484 A CA002086484 A CA 002086484A CA 2086484 A CA2086484 A CA 2086484A CA 2086484 A1 CA2086484 A1 CA 2086484A1
- Authority
- CA
- Canada
- Prior art keywords
- needle
- plug
- filament
- implantable access
- ball
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000001802 infusion Methods 0.000 title claims abstract description 14
- 238000007789 sealing Methods 0.000 claims abstract description 44
- 239000000463 material Substances 0.000 claims abstract description 13
- 229910052751 metal Inorganic materials 0.000 claims abstract description 9
- 239000002184 metal Substances 0.000 claims abstract description 8
- 239000013307 optical fiber Substances 0.000 claims abstract description 3
- 239000012530 fluid Substances 0.000 claims description 11
- 238000006073 displacement reaction Methods 0.000 claims description 4
- 238000003780 insertion Methods 0.000 claims description 4
- 230000037431 insertion Effects 0.000 claims description 4
- 230000006835 compression Effects 0.000 claims description 2
- 238000007906 compression Methods 0.000 claims description 2
- 239000007769 metal material Substances 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 230000006378 damage Effects 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 230000000149 penetrating effect Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010015866 Extravasation Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000036251 extravasation Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 235000019227 E-number Nutrition 0.000 description 1
- 239000004243 E-number Substances 0.000 description 1
- 101100366942 Mus musculus Ston1 gene Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940102689 lustra Drugs 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 description 1
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0208—Subcutaneous access sites for injecting or removing fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M39/0606—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof without means for adjusting the seal opening or pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0208—Subcutaneous access sites for injecting or removing fluids
- A61M2039/0211—Subcutaneous access sites for injecting or removing fluids with multiple chambers in a single site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/062—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof used with a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/0633—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof the seal being a passive seal made of a resilient material with or without an opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/0633—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof the seal being a passive seal made of a resilient material with or without an opening
- A61M2039/064—Slit-valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/0633—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof the seal being a passive seal made of a resilient material with or without an opening
- A61M2039/0653—Perforated disc
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/0633—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof the seal being a passive seal made of a resilient material with or without an opening
- A61M2039/0666—Flap-valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/0686—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof comprising more than one seal
Abstract
ABSTRACT OF THE DISCLOSURE
An infusion device which permits transcutaneous access to an implanted catheter for use in introducing an external filament such as a optical fiber, external catheter, guide wire or rigid needle. In accordance with this invention the device includes a valve assembly including a first valve element defining an aperture with a sealing member which is normally to engage and sea} against the aperture. The sealing element is made from a hard material such as a metal. Upon introduction of a rigid external introducer such as a needle, the needle directly contacts the sealing member plug unsealing it from the valve element aperture which then closes against the external element.
The device enables repeated access using a sharp introduced element such as a needle without it contacting soft sealing elements which could be degraded by such repeated access.
An infusion device which permits transcutaneous access to an implanted catheter for use in introducing an external filament such as a optical fiber, external catheter, guide wire or rigid needle. In accordance with this invention the device includes a valve assembly including a first valve element defining an aperture with a sealing member which is normally to engage and sea} against the aperture. The sealing element is made from a hard material such as a metal. Upon introduction of a rigid external introducer such as a needle, the needle directly contacts the sealing member plug unsealing it from the valve element aperture which then closes against the external element.
The device enables repeated access using a sharp introduced element such as a needle without it contacting soft sealing elements which could be degraded by such repeated access.
Description
: ~ 2~g~
IMPLANTABLE ACCESS DEVICE
Thi~ i~vention is xela~ed ~o a pa~ient a~ce~s dsvice and particularly ~o one which permits the ~ntroduc~ion o~ an external ~ilament such as a needle, ext~rnal ca~heter, guid~ wire, or optical ~iber transGutan~ou~
This inven~ion xelat~s to a device ~o ~nable multiple patient access proce~ures including in~using a therapeutic agent to a desired site within a patient, ~eed~ng a ~ilament to a desired internal site, or withdrawing a ~luid ~rom a patientJ and more partiaularly, to such a deYice which is implanted ~u~h that no portion i~ transcutaneous. It~ asc~ss portion is subcutaneous but designed so as to racili~at~ repeated aacess by th~
percutaneous route.
In curren~ human and ani~al medical pra~ics, there are numerous instanc~s where therapeutia agents must be delivered to a speci~ic organ or tissu~ wlthin the-~ody. An example i~ the infusion of chemotherapy into a central vein on a recurring ba~is over a lengthy treatment period ~or widespread sites of malignant ........
'.
.
~ ~ $ ~
~umor. Withou~ an access d~vice ~or intravenous ~rug infusion, multiple vein punctures over a lengthy period can result in progressive thrombosis, venous sclerosis, and destruction of small diameter pexipheral vessels. In other cases~ it may be desirable to infuse chemotherapy to a localized malignan~ tumor site. It may be difficult or impossible to ~eliver an agent speci~ically to such a site on a regular repeti~ive basis without surgically implanting an access system. Similarly, repeated arterial access is occasionally needed for injection of an X-ray dye or contrast agent into an artery ~or diagnos~ic purposes.
In other situations, there is a need to remove a body fluid from a remote body ~ite repeti~ively for analysis. Finally, sensing and physiological measuring devlces incorporated into small diameter cathe~ers and small diameter optical fibers are increasingly being utilized for monitoring body processes and could be more easily implemented through a properly designed access device with an adequate internal diameter.
In prior medical practice, peroutaneous catheters have been used to provide vascular or organ access ~or drug therapy or removing body fluids. Although such systems generally performed in a satis~actory manner, numerous problems were presented by such therapy approaches, including the substantial care requirements by patients, è.g. dressing changes with sterile techniques, a significant rate of infection o~ the catheter because o~ its transcutaneous position, and a high rate of venous thrombo~is, particularly if the catheter was located within an extremity vein.
Implantable infusion devices or "ports" have recently become available and are a significant advance over transcutaneous catheters. Pres~ntly available in~usion ports havs a number of common ~undamental design ~eatures. The ports themselves comprise a housing which ~orms a reservoir which can be constructed ~rom a varie~y o~ plastic or me~al materials. A
surface of the reservoir is enclosed by a high~density, salf sealing septum, typically made o~ silicone xubber. Connected to the port housi~g is an outflow catheter which communicates with a vein or other site within the patient where it is desired to infuse therapeutic agents. Implantation of such d vices generally proceeds by making a small sub~utaneous pocket in the patien~ under local anesthesia. The i~ternal out~low catheter is tunnelled to the desired infusion site and is connecteclto the infusion port. When the physician ~esires to infuse or remove material through the port, a hypodermi~ needle is used which pierces the skin over the infusion port and is placed into the port.
Although presently avàilable implantable infusion ports generally operate in a satisfactory mannex, they have a number of shortcomings. S~nce these devices rely on a compressed rubber septum for seallng, there are limitations in the diameter of needles which can be used to penetrate the septum, since large diameter needles can seriously damage the septum. These diameter limitations severely restrict the flow rate o~ fluids passing through the port. Moreover, the needles used must be of a special design which minimizes septum damage.
For prolonged in~usion using a conventional port, the `.infusion needle is taped to the patien~'s s~in to ~old it in position. Conventional ports do not allow the needle to penetrate deeply into the port; and consequently, a small displacement o~ the needl~ can causc it to be pulled ~rom the port, allowin~ ex~ravasation. In cases where locally toxic material~ are being in~used, extravasation o~ such materials can cause local tis~ue damage which can lead to a reguirement for corrective surgery such as skin gra~ting or removal of tissue.
Presently available implantable in~usion devices mus~ also have a signi~icant size to provide an acceptable target surface area for the physician who mus~ locate the port and penetrate the sep~um properly with a needle. ~ha port housing becomes bulky as the septum size increases since s~ructure is re~lired to maintain the septum in compr~ssion ~o provide el~-sealing a~ter the needle is removed. Moreover, presently available infusion ports are di~icult ~o ~lsar if thrombosis occurs within them or in the implanted outflow catheter, since it is difficult if not impossible to feed a cleaning wira through the penetrating hypodermic needle in a manner which will clear the :Ln~usion device and the i~ternal out~low catheter. Present inPusion ports have a space which contains a retained fluid volu~e beneath the self-sealing septum which increases the volume o~ drug which must be administered to enable a desired quantity ts reach the in~usion site. This retained volume also poses problems when a physician desires to deliver di~ferent drugs to the same infusion site which are incompatible or rendered less e~fective when mixed. In addition, when it is desired to withdraw blood through ~ h~6l~8 '~
the port, the retained volume o~ the prior art in~usion ports is an area where blood clotting can occur, ~hus in~er~ering with future access to the site. And finally, ~or present infusion ports, there is a risk that the physician attempting to pierce ~he port septum will not properly enter it, leading to the po sibility o~ extravasation which can cause signi~icant undesirable cons~guences as mentioned previously.
In applicants~ related patent application and issued patents, various approaches toward permitting transcutaneous access to implanted cathe~er are described. In accordance with those devices, multiple sealing members are us d to provide an adequate fluid seal across the access device, both when an external filament i8 introduced into the dsvice and a~ter it is removed. Th~ acce s ports in accordance with this invention achieve simplicity in construction and reduce ~he number o~
components necessary to provide the ne~essary ~luid seal. In those applications where it i8 desired to access a port using a sharp needle, damage to elas~omeric sealing elements can occur over repeated entries to the port in prior port designs. In accordanc with this invention, the implanted port has an articulating valve mechanism in which the accessing needle (or other filament~ contacts a hard material such as a metal to open the valve. ~ccordingly, a durable device is provided which is not damaged through long term use.
~ he ~eatures of the present invention are primarily achieved through use o~ a valve asse~bly in which a sealing elemen~ is normally maintained in contac~ with a valve seat. When introducing an external ~ilamen~, which may be a needle, 2 ~ 8 l~
catheter, wire, optical ~iber etc., ~he filament engages ~he sealing element forcing it ~rom engagement with the valve s~at.
once fully inserted into the access device, fea~ures are providsd to assure a ~luid ~eal around the introduced ~ilament.
Additional benefit~ and advantages o~ the present invention will become apparent to those skillsd in the art to wh~ch this invention relates from the subsequent description of the preferred embodiments and the appended olaims t taken in ~onjunction with the accompanying drawings~
BRIEF DESCRIPTION OF THE DRA~WINGS
Figure 1 is a cross-sectional view through an access port in accordance wi~h a first embodiment of this invention shown in a normal condition in which an external ~ilament is not present within the device.
: Figure 2 is a somewhat enlarged cros~-sectional view of the access port of Figure 1 shown ~Yith an accessing needle penetrating the device.
Figure 3 is an exploded pictorial view o~ the valve assembly of the port shown in Figures 1 and 2.
Figure 4 is a cross-sectional view through an access port according to a second embodiment o~ this invention showing a valve assembly comprising metal seal elements affixed to a multi-lea~ elastomeric valve disk.
Figure 5 is a ~rontal view of the valve assembly of the port shown in Figure 4.
Figure 6 is an exploded pictorial view of a valve assembly in accordance with a third embodiment o~ this invention fil incorporating a unl~ary seal member for sealing against the valve seat formed by a sealing disk.
Figure 7 is a cross-sectional view of an access port incorporating ~he valve assembly shown in Figure 6 and Purther showing an acce~sing needle penetrating the devi~e.
Figure 8 is a cross-sectional view taken through an access port in accordance with a ~ourth embodi~ent o~ this invention shown with an accessing needle partially penetrating the deYice.
Figure 9 is a cross-sec~ional view o~ the access port shown in Figure 8 but showing the accessing needle penetrating the valve asse~bly to pe~mit access to an implanted catheter.
~1 ' ~''' C~
An access device in accordance with this invention is shown in Figures 1 and 2, and is ~enerally designated by referen~e number 10. As shown, access port 10 is similar to that described in applicant~s issued patent nu~bers: 5,053,013 and 5,057,084, to which the present applica~ion is rela~ed. Access port 10 is designed to allow a sharp needle to access ~he device for purposes including infusing drugs or other ~luids in the patient or withdrawing ~luid~ from the patient. Access por~ 10 generally has housing 12 which defines a generally funnel shaped entrance orifice 14. Entrance orifice 14 has a decreasing cross-sectional area which ends at housing passageway 16~ The shape of entrance orifice 14 serves to guide a needle lnto passageway 16. To that end, the sur~a-e o~ housing 12 ~orming orifice 14 is a hardened material such as titanium which has been found to be acc~ptable for this application.
,~
.~
~ g3 8 ~ ~ 8 ~
Housing 12 together with outlet plug 18 define valve chamber ~ located between passageways ~6 and 22. As shown, the protruding catheter connector tube 24 of outlet plug 18 is bent to provide a positive means ~or preven*ing an introduced needle from passing e~tirely through the device and potentlally damaging a soft elastomeric impla~ted cathe~er 26. Connec~or tube 24 does, however, permi~ ~ore ~lexible ~ilaments such as a catheter, guide wire or optical ~iber to pass into implanted catheter 26.
~ounting pad 28 enables the device to he conveniently m~unted to subcutaneous support tissue pre~erably using sutures, staples, or other fasteners.
Valve asse~bly 34 is disposed within valve chamber 20 and is best described with reference to Figure 3. Valve disk 36 is made ~rom an elastomeric material such as silicone rubber and is positioned in valve chamber 20 alosest ~o entrance orifice 14.
Disk 36 has a central aperture 38 de~ining a valve seat which is intended to seal against the introduced needle ox ~ilament upon insertion into access po~t lO, as wlll be described in more detail as ~ollow~. Stacked directly against disk 36 is sealing member 40 which is pre~erably made, at least partially, of a hard material such as a metal. Sealing member 40 as shown in Figures l, Z and 3 is a circular metal disk having three cuts intersecting at the center o~ the disk and extending radially to the outer perimeter but stopping short of the perimeter, thus defining three 6eparate cantilever supported }eaves 42. Each of leaves 42 is locally deflected ~rom the plane of ~he disk at the disk center to define a segment 43 which combine to define conical sealing plug 44. Plug 44 has an external generally :
.i,~, conical surface 4~ with its oen~er de~ining~-~b~o~e sur~ace 48.
~ Sealing member 40 can be made ~rom a ~lat sheet metal stock which .~ is locally deflected at the center area to define plug 44.
Alternatively, the disk can be machined or cast such that the -, plug 44 is defined by a locally thickened region of the disk.
Valve asse~bly 34 also incorporates an additional lea~let ~ valve element 52 formed ~rom a ~lat sheet o~ elastomeric j material. Valve el~ment 52 defines radial cuts which join at the geometric center o~ the disk, defining separate valve leaves 54.
As shown 1n Figures 1 and 2, the three elements comprising valve assembly 3~ namely, valve disk 36, sealing member 40 and lea~let valve 52 are stacked directly against one another and are trapped in position between access port housing 12 and outlet ., plug 18. As shown in the Figure~, housing 12 defines a rela~ively smAll diameter passageway on the side of valve assembly 34 closest to entrance passageway 16~ In this manner, seal element 36 is constrained against de~lecting toward entrance orifice 14 except at near its central area de~ining aperture 38.
On the opposite side of valve assembly 34, outlet plug 18 defines a large diameter area ~or the deflection o~ the leaves of valve elements 40 and 52.
The operation and cooperation of ~he elements defining access port l0 will now be described with particular ref~rence to Figures 1 and 2. Figure 1 shows ~he con~iguration of valve assembly 34 when access port 10 is in its normal condition, implanted within the patient and not being used for access. In that condition, the segments o~ sealing member 40 making up sealing plug 44 project into and seal against disX aperture 38 _g_ which acts as a valve seat. Plug 44, having a conical outside sur~ace 46, presses against disk aperture 38, causing it to be stretched and enlarged. ~u~ to the contact between disk 36 and sealing me~ber 40, a seal against fluid leakage is provided.
` Leaflet valve element 52 ie provided to en~ance the level -. o~ sealing by preventing fluid leakag~ between sealing member leaves 42. In the normal condition o~ the device as shown in Figure l, the valve leave~ 54 meet to provide a ~luid seal. As ; ' shown in Figure 3, as a means of providing enhanced fluid ' sealing, the orientation of the cu~s defining leaflet valve i leaves ~4 and the cuts de~ining ~he ~ndividual sealing member leaves 42 are off~set or indexed so that they are not in : . registry.
Figure 2 shows the orientation of the elements o~ access port 10 upon insertion of accessing ext~rnal needle 58. Housing orifice 14 and passageway 16 serve to direct and orient needle 58 such that the sharp point o~ the needle strikes concave surface 48 o~ plug 44. Due to the enlargement o~ valve disk aperture 38 through i~s interaction with plug 44, the sharp point of the needle does not strike valve disk 36. As needle 58 is forced through the device, sealing member leave~ 42 are forced to deflect in th~ direction of the outlet plug pa~sageway 22.
This movement o~ leaves 42 causes ~he segments defining plug 44 to move from engagement with disk aperture 38 which is allowed to contract in diameter. The undeformed diameter of aperture 38 is selected so that it wi}l ~orm a fluid seal against needle 58 (or another introduced filament such as a catheter around the Y, needle whi~h can be left in the dev1ce after the needle is .i ~ -10-'~ ' "~i s removed~. Continued de~lec~ion of leaves 42 allows free passage o~ the needle 58. Such de~lsctions also causes valve leaves S4 .' to separate, allowing passage of needle 58 but without beinq damaged by contact with the needle point.
', ~s is eviden~ from ~he above descrip~ion of the operation 3 of access port 10, repe~ted access using needl~ 58 will not t damage the device ~ince th~ needle r~peatedly strikes the hard material forming plug 44~ ~ccess port 10 al~s permits the introduction of other external ~ilaments~ such as an external catheter, optical ~iber or gu~de wire, provided that it has t sufficient xigidity to deflect the valve elements in the manner previously described~ Acaess port 10 s~ould also enable external filaments to be introduced via needle 58 ei~her as fed through 2 its center passageway, or introduced around the need~.e like a ¦ typical angiography catheter.
,', Figure 4 i}lustra~es an access port 60 inoorporating a valve s a~sembly 6~ in accordance with the second embodiment o~ this invention. This embodiment, al~ng With ~hose described elsewhere in this specification have alements and features identical to . those of the ~irst embodiment, and are identified with like reference numbers. Figure 5 illustrates valve assembly 62 which includes a valve disk 36 identical to that previously described.
The distinction of this embodiment over valve assembly 34 is that the sealing member 64 which de~ines plug 70 is a composite structure. Sealing element 64 is formed ~rom an elastomeric or i flexible base disk 66 having a number of radially projecting cuts :! defining individual leaves 68 as in the case o~ sealing member ~ 40 described previously. Attached to leaves 68 near the center .,~ .
j -11-.3 ...... .
of base disk 66 ara plug segments 70 which together define a sealing plug 72 as in the prior embodiment which are made of a , hard material such as a metal. Plug elements 70 are bonded or ~ otherwise structurally a~fixed to disk 66.
'. In use, valve assembly 62 operates in a manner consistent with the description of valve assembly 34. A principle advantage ~t of the con~iguration o~ val~e assemb}y 6~ is ~hat 6ealing element ' disk 66 performs the combined ~unctions o~ se~ling as with the lea~let valve element 52 of the first embodiment, and *urther supports plug segments 70.
Figures 6 and 7 illustrate an acoes~ port 78 in accordanc~
with a third embodiment of this invention, Access port 78 has valve assembly 80 with a valve disk 36 identical to tha~ present in the first and second embodiments. In this en~odiment, : howeve.r, sealing member 8~ is a uni~ary s~ructure whia~l includes plug element ~4 attached to a mounting ring 86 via a cantilever arm 88. As with the prior embodiments, plug 84 de~ines an external conical surfac~ 90 and a central concave surface 92.
In this design, however, the plug 84 is a unitary element.
In operation, valve assembly ~0 opera~es as like those of ;3 the prior embodiments in that in a normal condition without an . external filame~t inserted within the access device, plug 84 is in sealing engagement with disk aperture 38. Upon the introduction of an extsrnal filament such as needle 58, engagement between the needle and sealing plug 84 urges it out of engagement with disk aperture 38, and deflects i~ suf~iciently to allow passage of the needle, as shown in Figure 7. This process also resu~ts in the contraction o~ the diameter of - ~, , f ~
aperture 38, causing it to constrict around the introduced filament. A signi~icant benefi~ of valve assemb~y 80 results s from the fact that plug ~4 i8 a unitary structure and, therefore, does not provide a fluid leakage path. In the normal condition with plug 84 against disk aperture 38, a ~luid seal is provided, and therefore, additional sealin~ elements such as a leaflet valve 52 shown in the ~irst embodiment are unnecessary.
Figures 8 and g provide an illustration of acaess port 102 in accordance with a fourth embodiment o~ this invention. T~is embodiment features a modi~ied housing 104 and outlet plug 106.
Housing 104 ~orms a small diameter counterbore 108 extending toward entrance orifice 14. Piston element 110 is positioned 1, within housing cavity 112 and includes a central filament passageway 114. Piston 110 butts against elasto~eric bushing 116 having passageway 117, which is trapped within counterbore 10~.
1 The head of piston 110 forms a dished concave surface 118 which supports valve ball 120. Piston sur~ace 118 is ~ormed to position ball 120 such that it is displaced ~rom alignment with ~, piston passageway 114. Outlet plug ~06 ~orms a generally flat J surface 122 within housing cavity 112 which provides for movement of ball 120, ac is described in more detail below.
Operation o~ access port 102 will be described with reference to Figures 8 and 9. Figure 8 represents the orientation of the elements comprising the device while inserting access needle 58. As is shown in F1gure 8, access needle 58 engages ball 120 o~-centsr. Con~inued insertion o~ needle 58 causes ball 120 to be displaced upward to the position shown in Figure 9. During such displacement, piston 110 is caused to move toward entrance orifice 14 as ball 120 ~rides out" of concave surface 118. This displacement o~ piston llO compresses bushing 116. Since bushing 116 is trapped within counterbore 108 its axial compression causes bushing passageway 117 to cons~rict, thus causing it to seal against the introduced needle or other ~ilament. As show~ in Figure 9, once ball 120 is fully displaced, free passage to the exit passageway 1~4 is provided.
When needle 58 is completely removed from the device, ball lZ0 reseats in position within concave surface 118 which provides a ~luid seal. It would be possible to enhance the fluid seal provided by ball 120 in i~8 normal position by providing an 0-ring or other elastomeric valve seat (not shown) installed either on outle~ plug 106 or a piston l~0 and engaging the ball.
While the abo~e descrip~ion constitutes ~he preferred embodiments o~ the present inv~ntivn, it will be appreciated that the invention is susceptible o~ modification, variation and change without ~epart1ng from the proper scope and fair meaning of the accompanying claims.
IMPLANTABLE ACCESS DEVICE
Thi~ i~vention is xela~ed ~o a pa~ient a~ce~s dsvice and particularly ~o one which permits the ~ntroduc~ion o~ an external ~ilament such as a needle, ext~rnal ca~heter, guid~ wire, or optical ~iber transGutan~ou~
This inven~ion xelat~s to a device ~o ~nable multiple patient access proce~ures including in~using a therapeutic agent to a desired site within a patient, ~eed~ng a ~ilament to a desired internal site, or withdrawing a ~luid ~rom a patientJ and more partiaularly, to such a deYice which is implanted ~u~h that no portion i~ transcutaneous. It~ asc~ss portion is subcutaneous but designed so as to racili~at~ repeated aacess by th~
percutaneous route.
In curren~ human and ani~al medical pra~ics, there are numerous instanc~s where therapeutia agents must be delivered to a speci~ic organ or tissu~ wlthin the-~ody. An example i~ the infusion of chemotherapy into a central vein on a recurring ba~is over a lengthy treatment period ~or widespread sites of malignant ........
'.
.
~ ~ $ ~
~umor. Withou~ an access d~vice ~or intravenous ~rug infusion, multiple vein punctures over a lengthy period can result in progressive thrombosis, venous sclerosis, and destruction of small diameter pexipheral vessels. In other cases~ it may be desirable to infuse chemotherapy to a localized malignan~ tumor site. It may be difficult or impossible to ~eliver an agent speci~ically to such a site on a regular repeti~ive basis without surgically implanting an access system. Similarly, repeated arterial access is occasionally needed for injection of an X-ray dye or contrast agent into an artery ~or diagnos~ic purposes.
In other situations, there is a need to remove a body fluid from a remote body ~ite repeti~ively for analysis. Finally, sensing and physiological measuring devlces incorporated into small diameter cathe~ers and small diameter optical fibers are increasingly being utilized for monitoring body processes and could be more easily implemented through a properly designed access device with an adequate internal diameter.
In prior medical practice, peroutaneous catheters have been used to provide vascular or organ access ~or drug therapy or removing body fluids. Although such systems generally performed in a satis~actory manner, numerous problems were presented by such therapy approaches, including the substantial care requirements by patients, è.g. dressing changes with sterile techniques, a significant rate of infection o~ the catheter because o~ its transcutaneous position, and a high rate of venous thrombo~is, particularly if the catheter was located within an extremity vein.
Implantable infusion devices or "ports" have recently become available and are a significant advance over transcutaneous catheters. Pres~ntly available in~usion ports havs a number of common ~undamental design ~eatures. The ports themselves comprise a housing which ~orms a reservoir which can be constructed ~rom a varie~y o~ plastic or me~al materials. A
surface of the reservoir is enclosed by a high~density, salf sealing septum, typically made o~ silicone xubber. Connected to the port housi~g is an outflow catheter which communicates with a vein or other site within the patient where it is desired to infuse therapeutic agents. Implantation of such d vices generally proceeds by making a small sub~utaneous pocket in the patien~ under local anesthesia. The i~ternal out~low catheter is tunnelled to the desired infusion site and is connecteclto the infusion port. When the physician ~esires to infuse or remove material through the port, a hypodermi~ needle is used which pierces the skin over the infusion port and is placed into the port.
Although presently avàilable implantable infusion ports generally operate in a satisfactory mannex, they have a number of shortcomings. S~nce these devices rely on a compressed rubber septum for seallng, there are limitations in the diameter of needles which can be used to penetrate the septum, since large diameter needles can seriously damage the septum. These diameter limitations severely restrict the flow rate o~ fluids passing through the port. Moreover, the needles used must be of a special design which minimizes septum damage.
For prolonged in~usion using a conventional port, the `.infusion needle is taped to the patien~'s s~in to ~old it in position. Conventional ports do not allow the needle to penetrate deeply into the port; and consequently, a small displacement o~ the needl~ can causc it to be pulled ~rom the port, allowin~ ex~ravasation. In cases where locally toxic material~ are being in~used, extravasation o~ such materials can cause local tis~ue damage which can lead to a reguirement for corrective surgery such as skin gra~ting or removal of tissue.
Presently available implantable in~usion devices mus~ also have a signi~icant size to provide an acceptable target surface area for the physician who mus~ locate the port and penetrate the sep~um properly with a needle. ~ha port housing becomes bulky as the septum size increases since s~ructure is re~lired to maintain the septum in compr~ssion ~o provide el~-sealing a~ter the needle is removed. Moreover, presently available infusion ports are di~icult ~o ~lsar if thrombosis occurs within them or in the implanted outflow catheter, since it is difficult if not impossible to feed a cleaning wira through the penetrating hypodermic needle in a manner which will clear the :Ln~usion device and the i~ternal out~low catheter. Present inPusion ports have a space which contains a retained fluid volu~e beneath the self-sealing septum which increases the volume o~ drug which must be administered to enable a desired quantity ts reach the in~usion site. This retained volume also poses problems when a physician desires to deliver di~ferent drugs to the same infusion site which are incompatible or rendered less e~fective when mixed. In addition, when it is desired to withdraw blood through ~ h~6l~8 '~
the port, the retained volume o~ the prior art in~usion ports is an area where blood clotting can occur, ~hus in~er~ering with future access to the site. And finally, ~or present infusion ports, there is a risk that the physician attempting to pierce ~he port septum will not properly enter it, leading to the po sibility o~ extravasation which can cause signi~icant undesirable cons~guences as mentioned previously.
In applicants~ related patent application and issued patents, various approaches toward permitting transcutaneous access to implanted cathe~er are described. In accordance with those devices, multiple sealing members are us d to provide an adequate fluid seal across the access device, both when an external filament i8 introduced into the dsvice and a~ter it is removed. Th~ acce s ports in accordance with this invention achieve simplicity in construction and reduce ~he number o~
components necessary to provide the ne~essary ~luid seal. In those applications where it i8 desired to access a port using a sharp needle, damage to elas~omeric sealing elements can occur over repeated entries to the port in prior port designs. In accordanc with this invention, the implanted port has an articulating valve mechanism in which the accessing needle (or other filament~ contacts a hard material such as a metal to open the valve. ~ccordingly, a durable device is provided which is not damaged through long term use.
~ he ~eatures of the present invention are primarily achieved through use o~ a valve asse~bly in which a sealing elemen~ is normally maintained in contac~ with a valve seat. When introducing an external ~ilamen~, which may be a needle, 2 ~ 8 l~
catheter, wire, optical ~iber etc., ~he filament engages ~he sealing element forcing it ~rom engagement with the valve s~at.
once fully inserted into the access device, fea~ures are providsd to assure a ~luid ~eal around the introduced ~ilament.
Additional benefit~ and advantages o~ the present invention will become apparent to those skillsd in the art to wh~ch this invention relates from the subsequent description of the preferred embodiments and the appended olaims t taken in ~onjunction with the accompanying drawings~
BRIEF DESCRIPTION OF THE DRA~WINGS
Figure 1 is a cross-sectional view through an access port in accordance wi~h a first embodiment of this invention shown in a normal condition in which an external ~ilament is not present within the device.
: Figure 2 is a somewhat enlarged cros~-sectional view of the access port of Figure 1 shown ~Yith an accessing needle penetrating the device.
Figure 3 is an exploded pictorial view o~ the valve assembly of the port shown in Figures 1 and 2.
Figure 4 is a cross-sectional view through an access port according to a second embodiment o~ this invention showing a valve assembly comprising metal seal elements affixed to a multi-lea~ elastomeric valve disk.
Figure 5 is a ~rontal view of the valve assembly of the port shown in Figure 4.
Figure 6 is an exploded pictorial view of a valve assembly in accordance with a third embodiment o~ this invention fil incorporating a unl~ary seal member for sealing against the valve seat formed by a sealing disk.
Figure 7 is a cross-sectional view of an access port incorporating ~he valve assembly shown in Figure 6 and Purther showing an acce~sing needle penetrating the devi~e.
Figure 8 is a cross-sectional view taken through an access port in accordance with a ~ourth embodi~ent o~ this invention shown with an accessing needle partially penetrating the deYice.
Figure 9 is a cross-sec~ional view o~ the access port shown in Figure 8 but showing the accessing needle penetrating the valve asse~bly to pe~mit access to an implanted catheter.
~1 ' ~''' C~
An access device in accordance with this invention is shown in Figures 1 and 2, and is ~enerally designated by referen~e number 10. As shown, access port 10 is similar to that described in applicant~s issued patent nu~bers: 5,053,013 and 5,057,084, to which the present applica~ion is rela~ed. Access port 10 is designed to allow a sharp needle to access ~he device for purposes including infusing drugs or other ~luids in the patient or withdrawing ~luid~ from the patient. Access por~ 10 generally has housing 12 which defines a generally funnel shaped entrance orifice 14. Entrance orifice 14 has a decreasing cross-sectional area which ends at housing passageway 16~ The shape of entrance orifice 14 serves to guide a needle lnto passageway 16. To that end, the sur~a-e o~ housing 12 ~orming orifice 14 is a hardened material such as titanium which has been found to be acc~ptable for this application.
,~
.~
~ g3 8 ~ ~ 8 ~
Housing 12 together with outlet plug 18 define valve chamber ~ located between passageways ~6 and 22. As shown, the protruding catheter connector tube 24 of outlet plug 18 is bent to provide a positive means ~or preven*ing an introduced needle from passing e~tirely through the device and potentlally damaging a soft elastomeric impla~ted cathe~er 26. Connec~or tube 24 does, however, permi~ ~ore ~lexible ~ilaments such as a catheter, guide wire or optical ~iber to pass into implanted catheter 26.
~ounting pad 28 enables the device to he conveniently m~unted to subcutaneous support tissue pre~erably using sutures, staples, or other fasteners.
Valve asse~bly 34 is disposed within valve chamber 20 and is best described with reference to Figure 3. Valve disk 36 is made ~rom an elastomeric material such as silicone rubber and is positioned in valve chamber 20 alosest ~o entrance orifice 14.
Disk 36 has a central aperture 38 de~ining a valve seat which is intended to seal against the introduced needle ox ~ilament upon insertion into access po~t lO, as wlll be described in more detail as ~ollow~. Stacked directly against disk 36 is sealing member 40 which is pre~erably made, at least partially, of a hard material such as a metal. Sealing member 40 as shown in Figures l, Z and 3 is a circular metal disk having three cuts intersecting at the center o~ the disk and extending radially to the outer perimeter but stopping short of the perimeter, thus defining three 6eparate cantilever supported }eaves 42. Each of leaves 42 is locally deflected ~rom the plane of ~he disk at the disk center to define a segment 43 which combine to define conical sealing plug 44. Plug 44 has an external generally :
.i,~, conical surface 4~ with its oen~er de~ining~-~b~o~e sur~ace 48.
~ Sealing member 40 can be made ~rom a ~lat sheet metal stock which .~ is locally deflected at the center area to define plug 44.
Alternatively, the disk can be machined or cast such that the -, plug 44 is defined by a locally thickened region of the disk.
Valve asse~bly 34 also incorporates an additional lea~let ~ valve element 52 formed ~rom a ~lat sheet o~ elastomeric j material. Valve el~ment 52 defines radial cuts which join at the geometric center o~ the disk, defining separate valve leaves 54.
As shown 1n Figures 1 and 2, the three elements comprising valve assembly 3~ namely, valve disk 36, sealing member 40 and lea~let valve 52 are stacked directly against one another and are trapped in position between access port housing 12 and outlet ., plug 18. As shown in the Figure~, housing 12 defines a rela~ively smAll diameter passageway on the side of valve assembly 34 closest to entrance passageway 16~ In this manner, seal element 36 is constrained against de~lecting toward entrance orifice 14 except at near its central area de~ining aperture 38.
On the opposite side of valve assembly 34, outlet plug 18 defines a large diameter area ~or the deflection o~ the leaves of valve elements 40 and 52.
The operation and cooperation of ~he elements defining access port l0 will now be described with particular ref~rence to Figures 1 and 2. Figure 1 shows ~he con~iguration of valve assembly 34 when access port 10 is in its normal condition, implanted within the patient and not being used for access. In that condition, the segments o~ sealing member 40 making up sealing plug 44 project into and seal against disX aperture 38 _g_ which acts as a valve seat. Plug 44, having a conical outside sur~ace 46, presses against disk aperture 38, causing it to be stretched and enlarged. ~u~ to the contact between disk 36 and sealing me~ber 40, a seal against fluid leakage is provided.
` Leaflet valve element 52 ie provided to en~ance the level -. o~ sealing by preventing fluid leakag~ between sealing member leaves 42. In the normal condition o~ the device as shown in Figure l, the valve leave~ 54 meet to provide a ~luid seal. As ; ' shown in Figure 3, as a means of providing enhanced fluid ' sealing, the orientation of the cu~s defining leaflet valve i leaves ~4 and the cuts de~ining ~he ~ndividual sealing member leaves 42 are off~set or indexed so that they are not in : . registry.
Figure 2 shows the orientation of the elements o~ access port 10 upon insertion of accessing ext~rnal needle 58. Housing orifice 14 and passageway 16 serve to direct and orient needle 58 such that the sharp point o~ the needle strikes concave surface 48 o~ plug 44. Due to the enlargement o~ valve disk aperture 38 through i~s interaction with plug 44, the sharp point of the needle does not strike valve disk 36. As needle 58 is forced through the device, sealing member leave~ 42 are forced to deflect in th~ direction of the outlet plug pa~sageway 22.
This movement o~ leaves 42 causes ~he segments defining plug 44 to move from engagement with disk aperture 38 which is allowed to contract in diameter. The undeformed diameter of aperture 38 is selected so that it wi}l ~orm a fluid seal against needle 58 (or another introduced filament such as a catheter around the Y, needle whi~h can be left in the dev1ce after the needle is .i ~ -10-'~ ' "~i s removed~. Continued de~lec~ion of leaves 42 allows free passage o~ the needle 58. Such de~lsctions also causes valve leaves S4 .' to separate, allowing passage of needle 58 but without beinq damaged by contact with the needle point.
', ~s is eviden~ from ~he above descrip~ion of the operation 3 of access port 10, repe~ted access using needl~ 58 will not t damage the device ~ince th~ needle r~peatedly strikes the hard material forming plug 44~ ~ccess port 10 al~s permits the introduction of other external ~ilaments~ such as an external catheter, optical ~iber or gu~de wire, provided that it has t sufficient xigidity to deflect the valve elements in the manner previously described~ Acaess port 10 s~ould also enable external filaments to be introduced via needle 58 ei~her as fed through 2 its center passageway, or introduced around the need~.e like a ¦ typical angiography catheter.
,', Figure 4 i}lustra~es an access port 60 inoorporating a valve s a~sembly 6~ in accordance with the second embodiment o~ this invention. This embodiment, al~ng With ~hose described elsewhere in this specification have alements and features identical to . those of the ~irst embodiment, and are identified with like reference numbers. Figure 5 illustrates valve assembly 62 which includes a valve disk 36 identical to that previously described.
The distinction of this embodiment over valve assembly 34 is that the sealing member 64 which de~ines plug 70 is a composite structure. Sealing element 64 is formed ~rom an elastomeric or i flexible base disk 66 having a number of radially projecting cuts :! defining individual leaves 68 as in the case o~ sealing member ~ 40 described previously. Attached to leaves 68 near the center .,~ .
j -11-.3 ...... .
of base disk 66 ara plug segments 70 which together define a sealing plug 72 as in the prior embodiment which are made of a , hard material such as a metal. Plug elements 70 are bonded or ~ otherwise structurally a~fixed to disk 66.
'. In use, valve assembly 62 operates in a manner consistent with the description of valve assembly 34. A principle advantage ~t of the con~iguration o~ val~e assemb}y 6~ is ~hat 6ealing element ' disk 66 performs the combined ~unctions o~ se~ling as with the lea~let valve element 52 of the first embodiment, and *urther supports plug segments 70.
Figures 6 and 7 illustrate an acoes~ port 78 in accordanc~
with a third embodiment of this invention, Access port 78 has valve assembly 80 with a valve disk 36 identical to tha~ present in the first and second embodiments. In this en~odiment, : howeve.r, sealing member 8~ is a uni~ary s~ructure whia~l includes plug element ~4 attached to a mounting ring 86 via a cantilever arm 88. As with the prior embodiments, plug 84 de~ines an external conical surfac~ 90 and a central concave surface 92.
In this design, however, the plug 84 is a unitary element.
In operation, valve assembly ~0 opera~es as like those of ;3 the prior embodiments in that in a normal condition without an . external filame~t inserted within the access device, plug 84 is in sealing engagement with disk aperture 38. Upon the introduction of an extsrnal filament such as needle 58, engagement between the needle and sealing plug 84 urges it out of engagement with disk aperture 38, and deflects i~ suf~iciently to allow passage of the needle, as shown in Figure 7. This process also resu~ts in the contraction o~ the diameter of - ~, , f ~
aperture 38, causing it to constrict around the introduced filament. A signi~icant benefi~ of valve assemb~y 80 results s from the fact that plug ~4 i8 a unitary structure and, therefore, does not provide a fluid leakage path. In the normal condition with plug 84 against disk aperture 38, a ~luid seal is provided, and therefore, additional sealin~ elements such as a leaflet valve 52 shown in the ~irst embodiment are unnecessary.
Figures 8 and g provide an illustration of acaess port 102 in accordance with a fourth embodiment o~ this invention. T~is embodiment features a modi~ied housing 104 and outlet plug 106.
Housing 104 ~orms a small diameter counterbore 108 extending toward entrance orifice 14. Piston element 110 is positioned 1, within housing cavity 112 and includes a central filament passageway 114. Piston 110 butts against elasto~eric bushing 116 having passageway 117, which is trapped within counterbore 10~.
1 The head of piston 110 forms a dished concave surface 118 which supports valve ball 120. Piston sur~ace 118 is ~ormed to position ball 120 such that it is displaced ~rom alignment with ~, piston passageway 114. Outlet plug ~06 ~orms a generally flat J surface 122 within housing cavity 112 which provides for movement of ball 120, ac is described in more detail below.
Operation o~ access port 102 will be described with reference to Figures 8 and 9. Figure 8 represents the orientation of the elements comprising the device while inserting access needle 58. As is shown in F1gure 8, access needle 58 engages ball 120 o~-centsr. Con~inued insertion o~ needle 58 causes ball 120 to be displaced upward to the position shown in Figure 9. During such displacement, piston 110 is caused to move toward entrance orifice 14 as ball 120 ~rides out" of concave surface 118. This displacement o~ piston llO compresses bushing 116. Since bushing 116 is trapped within counterbore 108 its axial compression causes bushing passageway 117 to cons~rict, thus causing it to seal against the introduced needle or other ~ilament. As show~ in Figure 9, once ball 120 is fully displaced, free passage to the exit passageway 1~4 is provided.
When needle 58 is completely removed from the device, ball lZ0 reseats in position within concave surface 118 which provides a ~luid seal. It would be possible to enhance the fluid seal provided by ball 120 in i~8 normal position by providing an 0-ring or other elastomeric valve seat (not shown) installed either on outle~ plug 106 or a piston l~0 and engaging the ball.
While the abo~e descrip~ion constitutes ~he preferred embodiments o~ the present inv~ntivn, it will be appreciated that the invention is susceptible o~ modification, variation and change without ~epart1ng from the proper scope and fair meaning of the accompanying claims.
Claims (21)
1. An implantable patient access port to permit the introduction of a needle for the removal or infusion of a fluid through an implanted catheter or permitting the introduction of a filament such as an external catheter, guide wire or optical fiber, comprising:
a housing defining a generally funnel shaped entrance orifice for guiding said needle into a housing entrance passageway, said housing further having an exit passageway with a valve chamber within said housing between said entrance and exit passageways, said housing further having means for connecting said exit passageway to said implanted catheter, an elastomeric valve element positioned within said valve chamber and having an aperture positioned in alignment with said housing entrance passageway, a plug which is normally biased into sealing engagement with said valve element aperture, at least a portion of said plug being formed of a hard material for repeated engagement with said needle, said plug positioned within said valve chamber such that upon insertion of said needle and engagement with said plug said plug is forced to deflect out of sealing engagement with said aperture, and mounting means formed by said housing enabling fastening of said housing subcutaneously.
a housing defining a generally funnel shaped entrance orifice for guiding said needle into a housing entrance passageway, said housing further having an exit passageway with a valve chamber within said housing between said entrance and exit passageways, said housing further having means for connecting said exit passageway to said implanted catheter, an elastomeric valve element positioned within said valve chamber and having an aperture positioned in alignment with said housing entrance passageway, a plug which is normally biased into sealing engagement with said valve element aperture, at least a portion of said plug being formed of a hard material for repeated engagement with said needle, said plug positioned within said valve chamber such that upon insertion of said needle and engagement with said plug said plug is forced to deflect out of sealing engagement with said aperture, and mounting means formed by said housing enabling fastening of said housing subcutaneously.
2. An implantable access port according to Claim 1 wherein said aperture is circular.
3. An implantable access port according to Claim 1 wherein said plug is shaped to extend partially through and expand said valve element aperture when said needle or external filament is not within said housing and wherein said valve element aperture constricts into sealing engagement with said external filament upon said plug being forced from sealing engagement with said aperture.
4. An implantable access port according to Claim 1 wherein said plug defines a convex outer surface which engages with said valve element apertures and aids in expanding said valve element aperture.
5. An implantable access port according to Claim 1 wherein said housing passageway is oriented with respect to said plug whereby upon introduction of said needle or external filament, said needle or filament contacts said plug and is prevented from contacting said sealing element.
6. An implantable access port according to Claim 1 wherein said plug defines a concave central area which is engaged by said needle or external filament.
7. An implantable access port according to Claim 1 wherein said plug is at least partially formed of a metal material defining a hard surface which is contacted by said needle or external filament upon introduction of said needle or external filament and said hard surface resisting being damaged or gouged by said needle.
8. An implantable patient access port according to Claim 1 wherein said sealing member comprises a disk having plural leaves which join at near the center of said disk to define said plug.
9. An implantable access port according to Claim 8 wherein said plug is defined by a plug segment disposed at the center region of each of said leaves.
10. An implantable access port according to Claim 8 wherein said sealing means disk is made of metal and wherein said plug segments are formed integrally by said disk.
11. An implantable access port according to Claim 8 wherein said plug segments are formed by separate metal elements bonded to a substrate.
12. An implantable access port according to Claim 1 wherein said plug is supported by an arm urging said plug into engagement with said valve element aperture.
13. An implantable access device according to Claim 1 wherein said plug defines a convex shaped outer surface which engages said valve element aperture with a concave central region for engaging said needle or filament.
14. An implantable access device according to Claim 1 further comprising a second elastomeric valve element disposed in engagement with said elastomeric valve element and positioned adjacent said exit passageway.
15. An implantable access device according to Claim 14 wherein said second elastomeric valve element comprises a leaflet valve having plural leaves which join near the center of said valve.
16. An implantable access port according to Claim 1 wherein said plug is in the form of a sealing ball element disposed within said valve chamber, and wherein said valve element is disposed in said housing valve chamber defining a ball seat wherein when said ball element rests on said ball seat, fluid flow between said entrance and exit passageways is inhibited, said ball seat positioning said ball such that said needle or filament engages said ball and displaces said ball from sealing contact with said ball seat thereby allowing said needle or filament to enter said exit passageway, said ball being resiliently biased into engagement with said seat when said needle or filament is removed.
17. An implantable access device according to Claim 16 wherein said ball seat positions said ball off-center with respect to the longitudinal axes of said entrance and exit passageways.
18. An implantable access device according to Claim 16 wherein said ball seat is defined by a piston member which is resiliently biased by an elastomeric biasing member.
19. An implantable access device according to Claim 18 wherein said piston member is caused to be displaced toward said entrance orifice upon said ball being displaced allowing passage of said external filament.
20. An implantable access device according to Claim 19 wherein said elastomeric biasing member comprises a bushing having a central passageway through which said needle or external filament passes upon introduction of said needle or filament and wherein compression of said bushing caused by displacement of said ball element causes said central passageway to constrict into sealing engagement with said needle or filament.
21. An implantable access device according to Claim 16 wherein said sealing ball element is formed of a hard material which is not gouged or damaged by engagement by said needle.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/818,626 US5226879A (en) | 1990-03-01 | 1992-01-10 | Implantable access device |
US818,626 | 1992-01-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2086484A1 true CA2086484A1 (en) | 1993-07-11 |
Family
ID=25225992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002086484A Abandoned CA2086484A1 (en) | 1992-01-10 | 1992-12-30 | Implantable infusion device |
Country Status (7)
Country | Link |
---|---|
US (1) | US5226879A (en) |
EP (1) | EP0551017B1 (en) |
JP (1) | JPH06142210A (en) |
AU (1) | AU653662B2 (en) |
CA (1) | CA2086484A1 (en) |
DE (1) | DE69224892T2 (en) |
ES (1) | ES2113930T3 (en) |
Families Citing this family (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5554117A (en) * | 1990-03-01 | 1996-09-10 | Michigan Transtech Corporation | Implantable access devices |
US5350360A (en) * | 1990-03-01 | 1994-09-27 | Michigan Transtech Corporation | Implantable access devices |
US6569120B1 (en) * | 1991-10-18 | 2003-05-27 | United States Surgical Corporation | Seal assembly |
US6981966B2 (en) * | 1991-10-18 | 2006-01-03 | United States Surgical | Valve assembly for introducing instruments into body cavities |
US20050096605A1 (en) * | 1992-04-24 | 2005-05-05 | Green David T. | Valve assembly for introducing instruments into body cavities |
US5397314A (en) * | 1992-10-09 | 1995-03-14 | Farley; Kevin | Surgical cannula with ball valve |
US5356394A (en) * | 1992-10-09 | 1994-10-18 | Kevin Farley | Cannula with ball valve |
US5354280A (en) * | 1993-02-19 | 1994-10-11 | Habley Medical Technology Corporation | Trocar and seal arrangement |
US5385552A (en) * | 1993-03-11 | 1995-01-31 | Habley Medical Technology Corporation | Trocar with overlapping seal elements |
US5391153A (en) * | 1993-04-09 | 1995-02-21 | Habley Medical Technology Corporation | Trocar with linear movement seal |
US5366446A (en) * | 1993-11-17 | 1994-11-22 | Unisurge, Inc. | Introducer assembly |
US6042569A (en) * | 1994-01-18 | 2000-03-28 | Vasca, Inc. | Subcutaneously implanted cannula and methods for vascular access |
US6929631B1 (en) * | 1994-01-18 | 2005-08-16 | Vasca, Inc. | Method and apparatus for percutaneously accessing a pressure activated implanted port |
US5460616A (en) * | 1994-04-19 | 1995-10-24 | Cordis Corporation | Catheter introducer with fluid chamber valve |
US5453095A (en) * | 1994-06-07 | 1995-09-26 | Cordis Corporation | One piece self-aligning, self-lubricating catheter valve |
US5741228A (en) * | 1995-02-17 | 1998-04-21 | Strato/Infusaid | Implantable access device |
WO1996036297A1 (en) * | 1995-05-19 | 1996-11-21 | Kanji Inoue | Transplantation instrument, method of bending same and method of transplanting same |
US6206851B1 (en) | 1995-06-07 | 2001-03-27 | Biolink Corporation | Hemodialysis access apparatus |
US5954691A (en) * | 1995-06-07 | 1999-09-21 | Biolink Corporation | Hemodialysis access apparatus |
US5743883A (en) * | 1995-06-07 | 1998-04-28 | Visconti; Peter L. | Thoracentesis catheter instruments having self-sealing valves |
US5788676A (en) * | 1996-03-25 | 1998-08-04 | Yoon; Inbae | Endoscopic portal having multiple universal seals and method of introducing instruments therethrough |
US5951512A (en) * | 1996-05-28 | 1999-09-14 | Horizon Medical Products, Inc. | Infusion port with modified drug reservoir |
US5820606A (en) * | 1996-06-11 | 1998-10-13 | Origin Medsystems, Inc. | Reusable cannula with disposable seal |
US6013058A (en) * | 1996-06-12 | 2000-01-11 | Biolink Corporation | Device for subcutaneous accessibility |
US6146355A (en) * | 1996-12-30 | 2000-11-14 | Myelotec, Inc. | Steerable catheter |
US6213974B1 (en) | 1996-12-30 | 2001-04-10 | Visionary Biomedical, Inc. | Steerable catheter having segmented tip and one-piece inlet housing, and method of fabricating same |
US6142981A (en) * | 1997-01-07 | 2000-11-07 | Daig Corporation | Hemostasis valve |
US6007516A (en) * | 1997-01-21 | 1999-12-28 | Vasca, Inc. | Valve port and method for vascular access |
US5989239A (en) * | 1997-01-21 | 1999-11-23 | Vasca, Inc. | Method and apparatus for percutaneously accessing an implanted port |
US7056316B1 (en) * | 1997-01-21 | 2006-06-06 | Vasca, Inc. | Valve port and method for vascular access |
US5848989A (en) * | 1997-06-05 | 1998-12-15 | Davinci Biomedical Research Products, Inc. | Implantable port with low profile housing for delivery/collection of fluids and implantation method |
JP2001524330A (en) * | 1997-07-18 | 2001-12-04 | バスカ, インコーポレイテッド | Method and apparatus for percutaneous access to an implant port |
US6217556B1 (en) | 1998-03-19 | 2001-04-17 | Allegiance Corporation | Drainage catheter |
JP2955854B1 (en) * | 1998-04-24 | 1999-10-04 | 株式会社グッドマン | Hemostatic valve of catheter introducer |
US6036672A (en) * | 1998-05-12 | 2000-03-14 | Cabot Technology Corporation | Instrument seal |
DE69920365T2 (en) | 1998-10-13 | 2005-11-17 | Terumo K.K. | Self-retaining needle assembly and valve element to be applied therein |
US6607504B2 (en) | 2001-06-29 | 2003-08-19 | Scimed Life Systems, Inc. | Percutaneous access |
US6981977B2 (en) * | 2001-10-26 | 2006-01-03 | Atrium Medical Corporation | Body fluid cartridge exchange platform device |
US7318833B2 (en) | 2001-12-19 | 2008-01-15 | Nmt Medical, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
WO2003053493A2 (en) * | 2001-12-19 | 2003-07-03 | Nmt Medical, Inc. | Septal occluder and associated methods |
WO2003082076A2 (en) | 2002-03-25 | 2003-10-09 | Nmt Medical, Inc. | Patent foramen ovale (pfo) closure clips |
US7431729B2 (en) | 2002-06-05 | 2008-10-07 | Nmt Medical, Inc. | Patent foramen ovale (PFO) closure device with radial and circumferential support |
US7338465B2 (en) * | 2002-07-02 | 2008-03-04 | Patton Medical Devices, Lp | Infusion device and method thereof |
US20040127855A1 (en) * | 2002-10-10 | 2004-07-01 | Nmt Medical, Inc. | Hemostasis valve |
US7766820B2 (en) | 2002-10-25 | 2010-08-03 | Nmt Medical, Inc. | Expandable sheath tubing |
EP1562653A1 (en) * | 2002-11-06 | 2005-08-17 | NMT Medical, Inc. | Medical devices utilizing modified shape memory alloy |
AU2003294682A1 (en) | 2002-12-09 | 2004-06-30 | Nmt Medical, Inc. | Septal closure devices |
US20050020884A1 (en) * | 2003-02-25 | 2005-01-27 | Hart Charles C. | Surgical access system |
WO2004096316A2 (en) * | 2003-04-24 | 2004-11-11 | Medical Research Products-A, Inc. | Implantable medication delivery device having needle receiving slot |
US8480706B2 (en) | 2003-07-14 | 2013-07-09 | W.L. Gore & Associates, Inc. | Tubular patent foramen ovale (PFO) closure device with catch system |
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
WO2005006990A2 (en) | 2003-07-14 | 2005-01-27 | Nmt Medical, Inc. | Tubular patent foramen ovale (pfo) closure device with catch system |
US7963952B2 (en) | 2003-08-19 | 2011-06-21 | Wright Jr John A | Expandable sheath tubing |
US20050273119A1 (en) | 2003-12-09 | 2005-12-08 | Nmt Medical, Inc. | Double spiral patent foramen ovale closure clamp |
US7497850B2 (en) * | 2004-03-02 | 2009-03-03 | Infusion Systems, Llc | Medical device needle receiving port |
EP1737349A1 (en) | 2004-03-03 | 2007-01-03 | NMT Medical, Inc. | Delivery/recovery system for septal occluder |
US20050267524A1 (en) | 2004-04-09 | 2005-12-01 | Nmt Medical, Inc. | Split ends closure device |
US8361110B2 (en) | 2004-04-26 | 2013-01-29 | W.L. Gore & Associates, Inc. | Heart-shaped PFO closure device |
US7842053B2 (en) * | 2004-05-06 | 2010-11-30 | Nmt Medical, Inc. | Double coil occluder |
US8308760B2 (en) | 2004-05-06 | 2012-11-13 | W.L. Gore & Associates, Inc. | Delivery systems and methods for PFO closure device with two anchors |
WO2005110240A1 (en) | 2004-05-07 | 2005-11-24 | Nmt Medical, Inc. | Catching mechanisms for tubular septal occluder |
US7223257B2 (en) * | 2004-08-31 | 2007-05-29 | Igor Shubayev | Percutaneous vascular access device |
US20070191779A1 (en) * | 2004-08-31 | 2007-08-16 | Igor Shubayev | Percutaneous Vascular Access Device With External Disposable Connector |
CA2581677C (en) | 2004-09-24 | 2014-07-29 | Nmt Medical, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
US20060142798A1 (en) * | 2004-12-27 | 2006-06-29 | Holman Thomas J | Device and method for closing an opening in a body cavity or lumen |
EP1868507A1 (en) | 2005-03-18 | 2007-12-26 | NMT Medical, Inc. | Catch member for pfo occluder |
US7615035B2 (en) * | 2005-03-24 | 2009-11-10 | B. Braun Medical Inc. | Needleless access port valves |
US20070073250A1 (en) * | 2005-07-08 | 2007-03-29 | Schneiter James A | Implantable port |
US7731694B2 (en) * | 2005-10-24 | 2010-06-08 | Cardiac Pacemakers, Inc. | Hemostasis seal |
US20070167981A1 (en) | 2005-12-22 | 2007-07-19 | Nmt Medical, Inc. | Catch members for occluder devices |
US8551135B2 (en) | 2006-03-31 | 2013-10-08 | W.L. Gore & Associates, Inc. | Screw catch mechanism for PFO occluder and method of use |
US8870913B2 (en) | 2006-03-31 | 2014-10-28 | W.L. Gore & Associates, Inc. | Catch system with locking cap for patent foramen ovale (PFO) occluder |
JP2009532125A (en) | 2006-03-31 | 2009-09-10 | エヌエムティー メディカル, インコーポレイティッド | Deformable flap catch mechanism for occluder equipment |
JP4871055B2 (en) * | 2006-07-27 | 2012-02-08 | 日本コヴィディエン株式会社 | connector |
JP4909097B2 (en) * | 2007-01-17 | 2012-04-04 | 日本コヴィディエン株式会社 | Indwelling needle |
US9005242B2 (en) | 2007-04-05 | 2015-04-14 | W.L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
WO2008131167A1 (en) | 2007-04-18 | 2008-10-30 | Nmt Medical, Inc. | Flexible catheter system |
WO2009033177A1 (en) * | 2007-09-07 | 2009-03-12 | Imtec, Llc | Method and device for dialysis |
US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
US9421065B2 (en) | 2008-04-02 | 2016-08-23 | The Spectranetics Corporation | Liquid light-guide catheter with optically diverging tip |
US8979828B2 (en) | 2008-07-21 | 2015-03-17 | The Spectranetics Corporation | Tapered liquid light guide |
US20100152640A1 (en) * | 2008-09-05 | 2010-06-17 | Imtecbiomedical, Inc. | Methods and apparatus for vascular access |
US8956389B2 (en) | 2009-06-22 | 2015-02-17 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
US10143796B2 (en) | 2010-08-25 | 2018-12-04 | Medtronic, Inc. | Fluid delivery device refill access |
US9737660B2 (en) | 2010-08-25 | 2017-08-22 | Medtronic, Inc. | Drug infusion device with controllable valve |
WO2012064881A2 (en) | 2010-11-09 | 2012-05-18 | Frank Prosl | Hemodialysis access system |
US9162038B2 (en) | 2011-04-11 | 2015-10-20 | The Spectranetics Corporation | Needle and guidewire holder |
US10434292B2 (en) * | 2011-06-24 | 2019-10-08 | Access Closure | Method and devices for flow occlusion during device exchanges |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
WO2014116810A1 (en) | 2013-01-23 | 2014-07-31 | C.R. Bard, Inc. | Low-profile access port |
US11464960B2 (en) | 2013-01-23 | 2022-10-11 | C. R. Bard, Inc. | Low-profile single and dual vascular access device |
US11420033B2 (en) | 2013-01-23 | 2022-08-23 | C. R. Bard, Inc. | Low-profile single and dual vascular access device |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
WO2016201269A2 (en) | 2015-06-11 | 2016-12-15 | Proviflo, Llc | Graft-port hemodialysis systems, devices and methods |
EP3538198B1 (en) * | 2016-11-11 | 2021-11-03 | C.R. Bard, Inc. | Low-profile single and dual vascular access device |
EP3381501A1 (en) * | 2017-03-30 | 2018-10-03 | PFM Medical AG | Implantable access device for accessing the vascular system of a human or animal body |
USD870264S1 (en) | 2017-09-06 | 2019-12-17 | C. R. Bard, Inc. | Implantable apheresis port |
JP6811792B2 (en) * | 2019-02-14 | 2021-01-13 | ボルトン メディカル インコーポレイテッド | Hemostasis valve and delivery system |
Family Cites Families (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1296652A (en) * | 1961-05-08 | 1962-06-22 | Improvements to angle fittings for tracheostomy tubes | |
US3288137A (en) * | 1964-01-07 | 1966-11-29 | Douglas W Lund | Anchoring device |
US3402710A (en) * | 1966-06-27 | 1968-09-24 | Hydra Power Corp | Self-closing valve device for implantation in the human body |
US3565078A (en) * | 1969-04-25 | 1971-02-23 | Bard Inc C R | Quick disconnect catheter coupling |
US3699956A (en) * | 1970-10-01 | 1972-10-24 | Tecna Corp | Percutaneous lead device |
US4181132A (en) * | 1977-05-31 | 1980-01-01 | Parks Leon C | Method and apparatus for effecting hyperthermic treatment |
DE2817102C2 (en) * | 1978-04-19 | 1985-01-24 | Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg | Connector for plastic cannulas or venous catheters |
US4190040A (en) * | 1978-07-03 | 1980-02-26 | American Hospital Supply Corporation | Resealable puncture housing for surgical implantation |
US4230109A (en) * | 1978-08-21 | 1980-10-28 | Alan Geiss | Apparatus for securing couplings of intravenous and intra-arterial access systems |
US4256102A (en) * | 1979-05-14 | 1981-03-17 | Monaco Anthony P | Subcutaneous dialysis system |
US4810241A (en) * | 1980-06-09 | 1989-03-07 | Rogers Phillip P | Ambulatory dialysis system and connector |
US4439188A (en) * | 1980-09-15 | 1984-03-27 | Baxter Travenol Laboratories, Inc. | Tube connector |
US4578061A (en) * | 1980-10-28 | 1986-03-25 | Lemelson Jerome H | Injection catheter and method |
US4430081A (en) * | 1981-01-06 | 1984-02-07 | Cook, Inc. | Hemostasis sheath |
AT369268B (en) * | 1981-07-16 | 1982-12-27 | Trawoeger Werner | VALVE FOR SUPPLYING, CHECKING AND TAKING OUT ANY CONTAINER IN AN IMPLANTED CONTAINER |
DE3242870A1 (en) * | 1981-11-20 | 1983-06-01 | Machida Endoscope Co., Ltd., Tokyo | Arrangement for prevention of a return flow through the forceps insertion opening of an endoscope |
US4464178A (en) * | 1981-11-25 | 1984-08-07 | Dalton Michael J | Method and apparatus for administration of fluids |
US4425119A (en) * | 1982-01-25 | 1984-01-10 | Berglund Rickey T | Implantable device for intravascular access |
US4405320A (en) * | 1982-02-22 | 1983-09-20 | Renal Systems, Inc. | Septum retaining means for percutaneous device |
US4447237A (en) * | 1982-05-07 | 1984-05-08 | Dow Corning Corporation | Valving slit construction and cooperating assembly for penetrating the same |
US4491126A (en) * | 1982-07-06 | 1985-01-01 | Wilbur D. Smith | Method and apparatus for monitoring body parts of animals |
US4490137A (en) * | 1982-09-30 | 1984-12-25 | Moukheibir Nabil W | Surgically implantable peritoneal dialysis apparatus |
DE3309788C2 (en) * | 1983-03-18 | 1985-12-05 | Karl Dr. 6301 Pohlheim Aigner | Implantable injection catheter |
US4581020A (en) * | 1983-07-18 | 1986-04-08 | Trimedyne, Inc. | Medication delivery device and system for percutaneous administration of medication |
FR2551348B1 (en) * | 1983-09-02 | 1986-08-29 | Meriaux Henri | INFUSION DEVICE |
US4781693A (en) * | 1983-09-02 | 1988-11-01 | Minntech Corporation | Insulin dispenser for peritoneal cavity |
US4569675A (en) * | 1983-09-12 | 1986-02-11 | Infusaid Corporation | Transcutaneous infusion system |
US4543088A (en) * | 1983-11-07 | 1985-09-24 | American Hospital Supply Corporation | Self-sealing subcutaneous injection site |
US4623329A (en) * | 1983-12-15 | 1986-11-18 | The Procter & Gamble Company | Drainage and infusion catheters having a capillary sleeve forming a reservoir for a fluid antimicrobial agent |
US4547194A (en) * | 1984-03-16 | 1985-10-15 | Moorehead Harvey R | Hub assemblies and extensions for indwelling catheter tubes and method |
US4634422A (en) * | 1984-05-31 | 1987-01-06 | Adrian Kantrowitz | Percutaneous access device and method for implanting same |
JPS6145774A (en) * | 1984-08-07 | 1986-03-05 | テルモ株式会社 | Medical instrument |
US4578063A (en) * | 1984-09-14 | 1986-03-25 | W. L. Gore & Assoc., Inc. | Central venous catheter |
US4650473A (en) * | 1985-04-15 | 1987-03-17 | Warner-Lambert Company | Suturing saddle |
FR2582221B1 (en) * | 1985-05-21 | 1987-09-25 | Applied Precision Ltd | IMPLANTABLE CHRONIC INJECTION DEVICE FOR A SUBSTANCE, ESPECIALLY THERAPEUTIC |
US4645495A (en) * | 1985-06-26 | 1987-02-24 | Vaillancourt Vincent L | Vascular access implant needle patch |
DE3528878A1 (en) * | 1985-08-12 | 1987-02-19 | Sanden Hasko Von Dipl Ing Dr M | INTRAPERITONEAL CATHETER FOR THE INPUT OF LIQUID MEDICINAL PRODUCTS, IN PARTICULAR INSULIN |
US4692146A (en) * | 1985-10-24 | 1987-09-08 | Cormed, Inc. | Multiple vascular access port |
US4710174A (en) * | 1985-12-16 | 1987-12-01 | Surgical Engineering Associates, Inc. | Implantable infusion port |
US4673394A (en) * | 1986-01-17 | 1987-06-16 | Strato Medical Corporation | Implantable treatment reservoir |
US4790826A (en) * | 1986-03-28 | 1988-12-13 | Elftman Nancy W | Percutaneous access port |
US4695273A (en) * | 1986-04-08 | 1987-09-22 | I-Flow Corporation | Multiple needle holder and subcutaneous multiple channel infusion port |
US4712583A (en) * | 1986-05-27 | 1987-12-15 | Pacesetter Infusion, Ltd. | Precision passive flat-top valve for medication infusion system |
US4832054A (en) * | 1986-07-07 | 1989-05-23 | Medical Engineering Corporation | Septum |
US4781695A (en) * | 1986-07-11 | 1988-11-01 | Dalton Michael J | Implantable fluid dispenser |
US4704103A (en) * | 1986-08-21 | 1987-11-03 | Burron Medical Inc. | Implantable catheter means |
US4781680A (en) * | 1987-03-02 | 1988-11-01 | Vir Engineering | Resealable injection site |
US4886501A (en) * | 1987-08-25 | 1989-12-12 | Shiley Infusaid Inc. | Implantable device |
US4842591A (en) * | 1988-01-21 | 1989-06-27 | Luther Ronald B | Connector with one-way septum valve, and assembly |
US4978338A (en) * | 1988-04-21 | 1990-12-18 | Therex Corp. | Implantable infusion apparatus |
US4857053A (en) * | 1988-08-29 | 1989-08-15 | Dalton Michael J | Matrix septum |
US5041098A (en) * | 1989-05-19 | 1991-08-20 | Strato Medical Corporation | Vascular access system for extracorporeal treatment of blood |
US5057084A (en) * | 1990-03-01 | 1991-10-15 | The Regents Of The University Of Michigan | Implantable infusion device |
US5053013A (en) * | 1990-03-01 | 1991-10-01 | The Regents Of The University Of Michigan | Implantable infusion device |
US5180365A (en) * | 1990-03-01 | 1993-01-19 | Ensminger William D | Implantable infusion device |
-
1992
- 1992-01-10 US US07/818,626 patent/US5226879A/en not_active Expired - Fee Related
- 1992-12-30 CA CA002086484A patent/CA2086484A1/en not_active Abandoned
- 1992-12-31 DE DE69224892T patent/DE69224892T2/en not_active Expired - Fee Related
- 1992-12-31 ES ES92311887T patent/ES2113930T3/en not_active Expired - Lifetime
- 1992-12-31 AU AU30504/92A patent/AU653662B2/en not_active Ceased
- 1992-12-31 EP EP92311887A patent/EP0551017B1/en not_active Expired - Lifetime
-
1993
- 1993-01-11 JP JP5002796A patent/JPH06142210A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US5226879A (en) | 1993-07-13 |
AU653662B2 (en) | 1994-10-06 |
JPH06142210A (en) | 1994-05-24 |
DE69224892D1 (en) | 1998-04-30 |
EP0551017B1 (en) | 1998-03-25 |
DE69224892T2 (en) | 1998-09-17 |
EP0551017A1 (en) | 1993-07-14 |
AU3050492A (en) | 1993-07-15 |
ES2113930T3 (en) | 1998-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2086484A1 (en) | Implantable infusion device | |
US5053013A (en) | Implantable infusion device | |
US5556381A (en) | Implantable access devices | |
US5057084A (en) | Implantable infusion device | |
US5281199A (en) | Implantable access devices | |
US5356381A (en) | Implantable access devices | |
US5352204A (en) | Implantable access devices | |
US5263930A (en) | Implantable access devices | |
AU645803B2 (en) | Implantable infusion device | |
EP0809523B1 (en) | Implantable access device | |
US5607393A (en) | Implantable access devices | |
US20050209573A1 (en) | Method and apparatus for percutaneously accessing a pressure activated implanted port | |
US20050124980A1 (en) | Port stem marking for catheter placement | |
JP3137360B2 (en) | Chemical injection port | |
JP3447215B2 (en) | Chemical injection port | |
CA2281950A1 (en) | Implantable access devices | |
IE912287A1 (en) | Implantable infusion device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |